Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

ChEBI2015-09-14 更新2026-07-12 收录

癌症表观遗传学

宫颈癌分子病理

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-68339 数据链接链接失效反馈

官方服务：

资源简介：

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

创建时间：

2015-09-14

Epigenetic dysregulation from chromosomal transit in micronuclei [ATAC-Seq]. Epigenetic dysregulation from chromosomal transit in micronuclei [ATAC-Seq]

癌症表观遗传学

染色质可及性分析

Chromosomal instability (CIN) and epigenetic reprograming are characteristic of advanced and metastatic human cancers, yet whether they are mechanistically linked is unknown. Here we show that missegr

NIAID Data Ecosystem60

LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells. LncRNA TP53TG1 plays an anti-oncogenic role in cervical cancer by synthetically regulating transcriptome profile in HeLa cells

lncRNA功能机制

宫颈癌分子病理

Long non-coding RNAs (lncRNAs) have been extensively studied as key regulators of cancer development in various cancers. TP53TG1 is a newly identified lncRNA in recent years, and several studies have

NIAID Data Ecosystem60

sj-xlsx-6-cix-10.1177_11769351221115135 – Supplemental material for Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark

癌症表观遗传学

基因表达调控

Supplemental material, sj-xlsx-6-cix-10.1177_11769351221115135 for Global Gene Expression Regulation Mediated by TGFβ Through H3K9me3 Mark by Ankit Naik, Nidhi Dalpatraj and Noopur Thakur in Cancer In

DataCite Commons2024-08-28 更新40

Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients

癌症表观遗传学

药物耐药性

Several homeobox-related gene (HOX) transcription factors such as mesenchyme HOX-2 (MEOX2) have previously been associated with cancer drug resistance, malignant progression and/or clinical prognostic

DataONE2020-06-24 更新60

ChIP-seq analysis of H3K27ac changes in pancreatic cancer cells treated with EZH2 and KRAS inhibitors

癌症表观遗传学

癌症靶向治疗

Our study demonstrates that combined treatment with the EZH2 inhibitor tazemetostat and the KRAS inhibitor RMC-6236 markedly activates the expression of senescence-associated secretory phenotype (SASP

NIAID Data Ecosystem40

Interplay between promoter methylation and chromosomal loss in gene silencing at 3p11-p14 in cervical cancer

资源简介：

相关数据集